|
EP3804389A4
(en)
|
|
DYNAMIC DETERMINATION AND PUBLICATION OF AMF DE SECOURS
|
|
EP4463166A4
(en)
|
|
IRAQ-4 DEMOCRAFT AND USES OF IT
|
|
EP4282880A4
(en)
|
|
FULLY HUMAN BROAD-SPECTRUM NEUTRALIZING ANTIBODY 26E1 AGAINST CORONAVIRUS AND USE THEREOF
|
|
IL272253A
(en)
|
|
Preparations and methods for treating inflammatory conditions of the skin
|
|
EP4106870A4
(en)
|
|
COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL
|
|
EP4426313A4
(en)
|
|
Biosurfactant formulations for use in skin care and wound treatment
|
|
EP4595907A4
(en)
|
|
THERAPEUTIC INSTRUMENT AND SCREW
|
|
EP4291172A4
(en)
|
|
Formulation and device for cosmetic treatment of onychomycosis
|
|
EP4271344A4
(en)
|
|
PATIENT SUPPORT DEVICES AND NETWORKS OF MEDICAL DEVICES
|
|
EP4623840A4
(en)
|
|
EMERGENCY DEVICE AND SURGICAL INSTRUMENT
|
|
EP4305021A4
(en)
|
|
USP30 INHIBITORS AND USES THEREOF
|
|
EP4087616A4
(en)
|
|
DESIGN AND APPLICATION OF PROTEIN NANOPARTICLES
|
|
EP4272729A4
(en)
|
|
RECOMBINANT HUMAN HYALURONIDASE FORMULATION AND USE THEREOF
|
|
EP4255563A4
(en)
|
|
5'-O-PHENYLACETYLURIDINE AND THERAPEUTIC USE
|
|
EP4340613A4
(en)
|
|
Antimicrobial skin care composition and treatment
|
|
EP4280973B1
(en)
|
|
SOFT TISSUE IMPLANTS AND INSTRUMENTS
|
|
EP4114362A4
(en)
|
|
NANODRUG FORMULATIONS OF CANNABIDIOL AND THEIR METHODS OF USE
|
|
IL304542A
(en)
|
|
Treatment of inflammation using glucocorticoids and inhibitors of angiopoietin-like protein 7
|
|
IL313137A
(en)
|
|
Region 5' is untranslated and modified
|
|
EP4499105A4
(en)
|
|
IMPROVED THIOPURIN FORMULATION AND TREATMENT PROCEDURE
|
|
EP4445142A4
(en)
|
|
ASSESSMENT AND TREATMENT OF MELANOMAS
|
|
EP4277552A4
(en)
|
|
ORTHOPEDIC IMPLANT AND METHODS OF USE
|
|
EP4135644A4
(en)
|
|
DIAGNOSTIC AND THERAPEUTIC SPLINTS AND METHODS OF USE
|
|
IL309315A
(en)
|
|
Treatment of MST1-related diseases and disorders
|
|
PL27297S2
(en)
|
|
A device for cosmetic treatments
|